TR200003024T2 - İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller. - Google Patents

İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.

Info

Publication number
TR200003024T2
TR200003024T2 TR2000/03024T TR200003024T TR200003024T2 TR 200003024 T2 TR200003024 T2 TR 200003024T2 TR 2000/03024 T TR2000/03024 T TR 2000/03024T TR 200003024 T TR200003024 T TR 200003024T TR 200003024 T2 TR200003024 T2 TR 200003024T2
Authority
TR
Turkey
Prior art keywords
purification
sulfonation
solid phase
reducing agents
sulfonated
Prior art date
Application number
TR2000/03024T
Other languages
English (en)
Inventor
Maertens Geert
Louwagie Joost
Bosman Alfons
Sablon Erwin
Zrein Maan
Original Assignee
Innogenetics N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8237028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200003024(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics N.V. filed Critical Innogenetics N.V.
Publication of TR200003024T2 publication Critical patent/TR200003024T2/tr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Mevcut bulus; kati faz bagisiklik tahlil (immünoassay) ile ilgili olup, bahsedilen kati faz üzerinde, indirgeyici bir ajanin varliginda, bir antijenden olusmaktadir. Bunun yaninda, mevcut bulus; sistein içeren, rekombinant olarak tanimlanan bir proteini saflastirmak için bir metot ile ilgili olup, asagidaki basamaklarin en az 2, tercihen 3 veya 4'ü ve hatta daha çok da, tercihen tümünden olusmaktadir. (a) bir lisatin rekombinant tasiyici canli hücrelerinden sülfonasyonu veya guanidinyum klorürün varliginda, rekombinant tasiyici canli hücrelerinin belirtilerinin giderek kaybolmasi (lisis), arkasindan da hücre lisatanin sülfonasyonu, (b) tercihen, hücre kalintilarinin uzaklastirilmasindan sonra, bir zvitteryonik deterjan ile muamele, (c) rekombinant proteinin sülfonasyonlu versiyonunun saflastirilmasi veya ardisik olarak gerçeklestirilen zvitteryonik deterjanin uzaklastirilmasi ile, sülfonasyonlu rekombinant proteinin saflastirilmasi olup, bahsedilen saflastirma islemi, tercihen kromatog
TR2000/03024T 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller. TR200003024T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98870087 1998-04-17

Publications (1)

Publication Number Publication Date
TR200003024T2 true TR200003024T2 (tr) 2000-12-21

Family

ID=8237028

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2001/01648T TR200101648T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller
TR2002/02213T TR200202213T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller
TR2001/01647T TR200101647T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.
TR2000/03024T TR200003024T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
TR2001/01648T TR200101648T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller
TR2002/02213T TR200202213T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller
TR2001/01647T TR200101647T2 (tr) 1998-04-17 1999-04-15 İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.

Country Status (21)

Country Link
US (1) US7935490B2 (tr)
EP (2) EP1071955B2 (tr)
JP (2) JP2002512370A (tr)
KR (1) KR20010042807A (tr)
CN (1) CN1305589A (tr)
AT (2) ATE278960T1 (tr)
AU (1) AU751362B2 (tr)
BR (1) BRPI9909678B8 (tr)
CA (2) CA2658218C (tr)
CY (1) CY1108424T1 (tr)
CZ (1) CZ298268B6 (tr)
DE (2) DE69939132D1 (tr)
DK (2) DK1071955T4 (tr)
ES (2) ES2230851T5 (tr)
HU (1) HUP0101719A3 (tr)
IL (1) IL138791A0 (tr)
PL (1) PL343469A1 (tr)
PT (2) PT1071955E (tr)
TR (4) TR200101648T2 (tr)
WO (1) WO1999054735A1 (tr)
ZA (1) ZA200005445B (tr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090033B2 (en) * 1998-06-24 2007-12-19 Innogenetics N.V. Particles of hcv envelope proteins: use for vaccination
AU2001292151B2 (en) * 2000-08-17 2006-05-04 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
JP4261195B2 (ja) * 2001-04-24 2009-04-30 イノジェネティックス・ナムローゼ・フェンノートシャップ 酵母のコア−グリコシル化されたｈｃｖエンベロープタンパク質の発現
JP2004108914A (ja) * 2002-09-18 2004-04-08 Kudo Norio コラーゲンの測定方法
AU2003283365A1 (en) * 2002-11-08 2004-06-07 Innogenetics N.V. HCV vaccine compositions comprising E1 and NS3 peptides
US20050014136A1 (en) * 2003-05-28 2005-01-20 Innogenetics N.V. Modified HCV NS5
DE602004029707D1 (de) * 2003-10-28 2010-12-02 Advanced Life Science Inst Inc Verfahren zum nachweis von hepatitis-c-virus
US20090209737A1 (en) * 2006-07-07 2009-08-20 Pall Corporation Use of denaturing agents during affinity capture
MX2010000745A (es) * 2007-07-16 2010-05-20 Pfizer Procedimientos para mejorar un indice de marcador genomico de animales lecheros y productos lacteos.
WO2009035560A1 (en) * 2007-09-12 2009-03-19 Pfizer, Inc. Methods of using genetic markers and related epistatic interactions
MX2010003610A (es) * 2007-10-03 2010-04-30 Pfizer Marcadores geneticos para ganado astado y sin cuernos, y metodos relacionados.
AU2008343365A1 (en) * 2007-12-17 2009-07-09 Pfizer Inc. Methods of improving genetic profiles of dairy animals and products
JP5476376B2 (ja) * 2008-07-16 2014-04-23 ラジオメーター・メディカル・アー・ペー・エス 高性能固相
CN102081018A (zh) * 2009-11-30 2011-06-01 希森美康株式会社 样品的预处理方法及hcv的免疫测定方法
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
ES2828713T3 (es) * 2014-10-29 2021-05-27 Abbott Lab Ensayos de detección de anticuerpos anti-VHC objeto usando péptidos de captura NS3
CN109870581B (zh) * 2017-12-04 2021-05-04 厦门万泰凯瑞生物技术有限公司 一种定量检测HBsAg的试剂盒及方法
CN109678954B (zh) * 2018-12-29 2022-01-07 山东莱博生物科技有限公司 一对能够特异性识别hcv ns3蛋白的单克隆抗体及其应用
CN110988362B (zh) * 2019-12-20 2023-11-14 迈克生物股份有限公司 抗组蛋白抗体测定试剂、试剂盒及其使用方法
CN112225783B (zh) * 2020-09-16 2021-08-31 东莞市朋志生物科技有限公司 Hcv重组抗原及其突变体
CN112285361B (zh) * 2020-09-27 2023-12-05 中国人民解放军空军军医大学 排除抗-cd38单克隆抗体药物对抗人球蛋白检测干扰的试剂
CN113219169B (zh) * 2021-05-22 2021-12-17 北京金诺百泰生物技术有限公司 生物检测用封闭剂及其制备方法、包被板及应用该包被板的试剂盒
CN115112897B (zh) * 2021-12-10 2024-11-01 中山大学附属第八医院（深圳福田） 一种用于鉴别抗体检测生物学假阳性的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139526A2 (en) * 1983-10-20 1985-05-02 Warner-Lambert Company An insolubilized stable specific binding protein
US4616078A (en) * 1985-04-08 1986-10-07 Eli Lilly And Company Process for purifying proinsulin-like materials
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
DE68907996T2 (de) * 1988-05-11 1994-01-05 Abbott Lab Verfahren zur Erhöhung der Spezifizität in kompetitiven Immuntests.
US4923967A (en) * 1988-09-26 1990-05-08 Eli Lilly And Company Purification and refolding of recombinant proteins
DE69133617D1 (de) 1990-04-04 2009-07-23 Novartis Vaccines & Diagnostic Protease von Hepatitis C Virus
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
US5606031A (en) * 1990-04-06 1997-02-25 Lile; Jack Production and purification of biologically active recombinant neurotrophic protein in bacteria
KR0185426B1 (ko) * 1991-06-24 1999-04-01 로버트 피. 블랙버언 씨형 간염 바이러스 폴리펩티드
JP3225468B2 (ja) 1992-08-28 2001-11-05 ダイナボット株式会社 抗体測定用試薬
ATE551423T1 (de) 1993-04-27 2012-04-15 Innogenetics Nv Sequenzen von hepatitis c virus-genotypen sowie ihre verwendungen als therapeutika und diagnostika
PT992580E (pt) 1993-11-04 2005-07-29 Innogenetics Nv Epitopos para celulas t humanas imunodominantes do virus da hepatite c
WO1996000365A1 (en) 1994-06-23 1996-01-04 Energy Answers Corporation System for manufacturing ash products and energy from refuse waste
WO1996004385A2 (en) * 1994-07-29 1996-02-15 Innogenetics N.V. Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
JPH0862219A (ja) 1994-08-19 1996-03-08 Dainabotsuto Kk 還元型抗原に対する抗体アッセイ試薬及びそれを使用した測定方法
DE69526973T3 (de) 1994-10-21 2010-01-07 Innogenetics N.V. Sequenzen von hepatitis-c-virus genotype 7, und deren verwendung als vorbeugende, therapeutische und diagnostische mittel
US5705330A (en) 1995-04-14 1998-01-06 Abbott Laboratories Chemiluminescent immunoassay for antibody detection
US5616460A (en) * 1995-06-07 1997-04-01 Abbott Laboratories Buffer composition for reagents for immunoassay
JP3945822B2 (ja) 1996-05-24 2007-07-18 カイロン コーポレイション 複数エピトープ融合タンパク質
US6036579A (en) * 1997-01-13 2000-03-14 Rodel Inc. Polymeric polishing pad having photolithographically induced surface patterns(s) and methods relating thereto

Also Published As

Publication number Publication date
TR200202213T2 (tr) 2002-11-21
US7935490B2 (en) 2011-05-03
JP2005185285A (ja) 2005-07-14
ES2310701T3 (es) 2009-01-16
HK1036653A1 (en) 2002-01-11
US20060263854A1 (en) 2006-11-23
PL343469A1 (en) 2001-08-13
IL138791A0 (en) 2001-10-31
DK1471074T3 (da) 2008-11-17
EP1071955A1 (en) 2001-01-31
HUP0101719A2 (hu) 2001-09-28
HUP0101719A3 (en) 2006-05-29
CZ20003819A3 (cs) 2001-10-17
PT1071955E (pt) 2005-02-28
ES2230851T5 (es) 2009-06-25
JP3974620B2 (ja) 2007-09-12
DE69920895D1 (de) 2004-11-11
EP1471074A2 (en) 2004-10-27
ATE278960T1 (de) 2004-10-15
ATE401340T1 (de) 2008-08-15
JP2002512370A (ja) 2002-04-23
EP1471074A3 (en) 2004-11-10
EP1071955B1 (en) 2004-10-06
BR9909678A (pt) 2000-12-19
BR9909678B1 (pt) 2013-11-12
CA2658218C (en) 2014-10-28
KR20010042807A (ko) 2001-05-25
CA2658218A1 (en) 1999-10-28
DK1071955T4 (da) 2009-06-15
CA2324970A1 (en) 1999-10-28
TR200101648T2 (tr) 2002-06-21
ZA200005445B (en) 2003-01-06
BRPI9909678B8 (pt) 2021-05-25
EP1071955B2 (en) 2009-02-18
AU751362B2 (en) 2002-08-15
CN1305589A (zh) 2001-07-25
DE69939132D1 (de) 2008-08-28
TR200101647T2 (tr) 2002-06-21
DE69920895T2 (de) 2005-10-13
DE69920895T3 (de) 2009-09-03
CY1108424T1 (el) 2014-04-09
PT1471074E (pt) 2008-10-23
CZ298268B6 (cs) 2007-08-08
DK1071955T3 (da) 2005-02-07
ES2230851T3 (es) 2005-05-01
AU3817199A (en) 1999-11-08
CA2324970C (en) 2009-06-30
EP1471074B1 (en) 2008-07-16
WO1999054735A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
TR200101648T2 (tr) İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller
DE3485299D1 (de) Nachweis von antigen aktiven aminosaeurensequenzen.
ATE105867T1 (de) Immunaffinitäts-reinigungssystem.
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
ATE310019T1 (de) Citrullin-enthaltende fibrin-derivate und ihre verwendung zur diagnose und behandlung von rheumatischer arthritis
RU2000112540A (ru) Варианты протеазы, замещенные в нескольких положениях, с измененным суммарным зарядом и их применение в детергентах
Hurst et al. The structural basis for binding of complement by immunoglobulin M
ATE225511T1 (de) Entstörung von diagnostischen verfahren durch peptide aus d-aminosäuren
NO913037D0 (no) Peptider med for alfal-mikroglobulin karakteristiske antigene determinanter.
RU98106859A (ru) Новое антитело, соединение с активностью ренина, содержащее новое антитело, и реактив для определения проренина с использованием нового антитела
FR2709492B1 (fr) Méthode d'immunodosage spécifique de la glutathion peroxydase plasmatique humaine, kit pour sa mise en Óoeuvre, oligopeptides et anticorps spécifiques de la méthode .
BR0308095A (pt) Teste para anticorpos anti-ingap
BR9801000A (pt) Anticorpo, substância renina-ativa contendo o mesmo e reagente para ensaio de pro-renina usando o mesmo.
KR960034420A (ko) 적어도 2개의 c형간염바이러스관련펩티드로 이루어진 다량체항원펩티드
KR960014341A (ko) 톡소플라즈마 곤디의 항원
RU2000129528A (ru) Усовершенствованные иммунодиагностические анализы с использованием восстановителей
AU2002365248A1 (en) Detection of bovine viral diarrhea virus in hair samples
YAMAKI et al. Presence of lower temperature-dependent antibody with low avidity to C100-3 (HCV) antigen in voluntary blood donors
DK1096258T3 (da) Bestemmelse af proteiner, såsom immunoglobuliner af type E (IgE) i næsesekreter
ATE215387T1 (de) Verfahren zum entfernen von unkonventionellen krankheitserregern aus proteinlösungen
ПОЛТОРАК AND BIOCHEMICAL OLFACTORY MECHANISMS
UA58895A (uk) Тест-система імуноферментна (dia-chlamydia) для виявлення антитіл класів а та g до chlamydia trachomatis у сироватках та плазмі крові людини
TH36116A (th) แอนตีบอดีแบบใหม่ สารออกฤทธิ์-เรนิน ที่ประกอบด้วยแอนติบอดีชนิดเดียวกันนี้ และรีเอเจนท์สำหรับตรวจวิเคราะห์โพรเรนินโดยใช้แอนติบอดีดังกล่าว
TH9693B (th) แอนตีบอดีแบบใหม่ สารออกฤทธิ์-เรนิน ที่ประกอบด้วยแอนติบอดีชนิดเดียวกันนี้ และรีเอเจนท์สำหรับตรวจวิเคราะห์โพรเรนินโดยใช้แอนติบอดีดังกล่าว
KR950005322A (ko) 소의 소형 피로플라즈마 병원충 감염의 예방용 펩티드